Chongqing Huapont Pharm. Co., Ltd.

Huapont’s main businesses are manufacturing and supplying generic APIs to regulated markets, contract manufacturing for FDFs, APIs and intermediates and marketing finished dosage formulations. We have one R&D center and two API plants with capacity from grams to hundreds tons, besides our factories fully comply with GMP regulation and inspected by FDA and EDQM. Our primary API products include retinoids and antineoplastics, etc.